Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
Neuroleptic-induced akathisia (NIA) and parkinsonism (NIP) continued for 3 months, despite two courses of anticholinergic treatments, a shift to low-potent neuroleptic (NL) and a NL-free period. The two adverse effects responded dramatically to electroconvulsive therapy (ECT) to reemerge 3 months after termination of ECT. The case supports the idea that ECT is effective for both NIA and NIP even when they are resistant.
Hermesh
H
H
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tikva, Israel.
Aizenberg
D
D
Friedberg
G
G
Lapidot
M
M
Munitz
H
H
D000328:Adult; D017109:Akathisia, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009460:Neurologic Examination; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000628:therapy; D011595:Psychomotor Agitation / Q000628:therapy; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents